Skip to main content
Premium Trial:

Request an Annual Quote

International Workings

Not all collaborations are the same. NPR's Joe Palca reports that international collaborations are more likely to affect the wider scientific community.

Two ecologists — Stefano Allesina at the University of Chicago and the University of Florida's Emilio Bruna — became interested in whether there was a difference in what kind of journal the results from international collaborations were published in.

They thought that maybe "international collaboration and meeting and working with ecologists in other countries could be really beneficial to us as scientists," Bruna tells Palca.

Their team examined papers published in eight fields between 1996 and 2012 and reported in PLOS One earlier this year that the more countries listed among authors' affiliations, the better the papers did in terms of journal placement and citations.

"Your chances of getting into these top journals are much higher if you collaborate across nations," Allesina says. And then, he adds, citations rates, those articles have a higher impact that the typical articles in those journals because they are more highly cited.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.